Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension.

Journal: ERJ open research
Published Date: May 12, 2025

Abstract

BACKGROUND: Tricuspid regurgitation jet velocity (TRJV) on echocardiography is used for screening patients with suspected pulmonary hypertension (PH). Artificial intelligence (AI) tools, such as the US2.AI, have been developed for automated evaluation of echocardiograms and can yield measurements that aid PH detection. This study evaluated the performance and utility of the US2.AI in a consecutive cohort of patients with suspected PH.

Authors

  • Mahan Salehi
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Samer Alabed
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Michael Sharkey
    Department of Entomology, University of Kentucky, Lexington, KY, USA.
  • Ahmed Maiter
    Sheffield Teaching Hospitals NHS Foundation Trust, Department of Radiology, Sheffield, United Kingdom.
  • Krit Dwivedi
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Tarik Yardibi
    Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Mona Selej
    Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Abdul Hameed
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Athanasios Charalampopoulos
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • David G Kiely
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Andrew J Swift
    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals